First patient treated in Geron stem cell trial

WASHINGTON Mon Oct 11, 2010 8:30am EDT

WASHINGTON Oct 11 (Reuters) - Geron Corp (GERN.O) said on Monday that doctors have begun treating the first patient in the United States to receive human embryonic stem cells, but said the details of the landmark clinical trial are being kept confidential.

Geron has the first U.S. Food and Drug Administration license to use the controversial cells to treat people, in this case patients with new spinal cord injuries. (Reporting by Maggie Fox, editing by Gerald E. McCormick) ((Maggie.Fox@ThomsonReuters.com; Washington bureau newsroom 202-898-8492))

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.